Get informed when a big investor buys or sells
+ Follow$6.11
2 analysts in the last 4 months
High: $35 | Low: $16
No recommendations in the last 4 months.
As of the most recent data, HELP shows a target price of $26. Scroll down for historical charts and peer comparison views.
If Helus Pharma moved to the average analyst target of $26, shares would be roughly 317.3% higher than $6.11. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Helus Pharma's earnings trajectory.
Besides this target price page, Stockcircle has Helus Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $26) with ownership activity and broader fundamentals.
Helus Pharma's target price is $26; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.